MARI — Marinomed Biotech AG Balance Sheet
0.000.00%
Last trade - 00:00HealthcareBalancedMicro CapSucker Stock
- €56.21m
- €69.72m
- €11.63m
Annual balance sheet for Marinomed Biotech AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 6.03 | 1.72 | 12 | 9.21 | 5.8 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.61 | 1.53 | 3.17 | 5.18 | 4.81 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 7.85 | 3.72 | 15.3 | 15.4 | 12.9 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.163 | 0.195 | 2.49 | 6.04 | 6.43 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 9.33 | 5.26 | 19.5 | 23.5 | 21.3 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6.86 | 7.64 | 4.03 | 5.61 | 6.01 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 14.4 | 21.5 | 8.64 | 18.1 | 21.1 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -5.03 | -16.3 | 10.9 | 5.36 | 0.191 |
| Total Liabilities & Shareholders' Equity | 9.33 | 5.26 | 19.5 | 23.5 | 21.3 |
| Total Common Shares Outstanding |